Related Experiment Video
Updated: May 14, 2026

06:08
Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments
Published on: May 26, 2019
Radiobiological effects of altering dose rate in filter-free photon beams
1Medical Physics Department, Vancouver Cancer Centre, British Columbia Cancer Agency, Vancouver, Canada. tkaran@bccrc.ca
Physics in Medicine and Biology
|February 1, 2013
Summary
Altering radiotherapy dose rate does not affect cancer cell survival. Increasing dose rate is a safe method to reduce treatment time without harming in vitro cell eradication.
Area of Science:
- Radiation Oncology
- Cell Biology
- Medical Physics
Background:
- Radiotherapy treatment time can be reduced by increasing the dose rate.
- The effect of altered dose rates on cell survival requires further investigation.
Purpose of the Study:
- To validate if changing radiotherapy dose rate affects cell survival.
- To compare filtered and filter-free beam delivery modes.
- To assess the impact of dose protraction on cell survival.
Main Methods:
- Irradiation of human carcinoma and hamster lung cell lines using a Varian TrueBeam linac in flattening filter-free mode.
- Experiments involved varying pulse repetition frequency and instantaneous dose rate.
- Analysis of DNA double-strand breaks using the γH2AX assay.
Main Results:
- Altering dose rate by changing pulse repetition frequency or instantaneous dose rate had no effect on cell survival.
- No difference in cell survival was observed between filtered and filter-free beam delivery during protracted dose delivery.
- Protracted dose delivery (15, 30, or 60 min) increased cell survival compared to acute delivery in both filtered and filter-free modes.
- The γH2AX assay showed no difference in DNA double-strand breaks between filtered and unfiltered beams.
Conclusions:
- Increasing radiotherapy dose rate is an acceptable method to decrease treatment time.
- Altering dose rate does not detrimentally affect in vitro cell eradication.
- Filtered and filter-free beam delivery show comparable results in protracted dose schemes.

